Advanced search
Publication Cover
Journal of Psychoactive Drugs Volume 48, 2016 - Issue 3
Submit an article Journal homepage
556
Views
15
CrossRef citations to date
0
Altmetric
Articles

Remission of Severe Opioid Use Disorder with Ibogaine: A Case Report

Laurie Cloutier-GillDepartment of Medicine, University of British Columbia, Vancouver, BC, CanadaView further author information
, M.D.,
Evan WoodDepartment of Medicine, University of British Columbia, Vancouver, BC, Canada;British Columbia Centre for Excellence in HIV/AIDS, St. Paul’s Hospital, Vancouver, BC, CanadaCorrespondence[email protected]
View further author information
, M.D., Ph.D., A.B.I.M., F.R.C.P.C.,
Trevor MillarLiberty Root, Vancouver, BC, CanadaView further author information
,
Caroline FerrisPrimary Care and Addiction Medicine, Surrey, BC, CanadaView further author information
, M.D., C.C.F.P., F.C.F.P. &
M. Eugenia SociasDepartment of Medicine, University of British Columbia, Vancouver, BC, Canada;British Columbia Centre for Excellence in HIV/AIDS, St. Paul’s Hospital, Vancouver, BC, CanadaView further author information
, M.D., M.Sc.
Pages 214-217 | Received 19 Jan 2016, Accepted 28 Mar 2016, Published online: 18 May 2016

References

  • Alper, K. R. 2001. Ibogaine: A review. The Alkaloids: Chemistry and Biology 56:1–38.
  • Alper, K. R., H. S. Lotsof, and C. D. Kaplan. 2008. The ibogaine medical subculture. Journal of Ethnopharmacology 115 (1):9–24. doi:10.1016/j.jep.2007.08.034.
  • Alper, K. R., M. Stajic, and J. R. Gill. 2012. Fatalities temporally associated with the ingestion of ibogaine. Journal of Forensic Sciences 57 (2):398–412. doi:10.1111/j.1556-4029.2011.02008.x.
  • Antonio, T., S. R. Childers, R. B. Rothman, C. M. Dersch, C. King, M. Kuehne, W. G. Bornmann, A. J. Eshleman, A. Janowsky, E. R. Simon, M. E. Reith, and K. Alper. 2013. Effect of Iboga alkaloids on micro-opioid receptor-coupled G protein activation. PLoS One 8 (10):e77262. doi:10.1371/journal.pone.0077262.
  • Bogenschutz, M. P., and M. W. Johnson. 2016. Classic hallucinogens in the treatment of addictions. Progress in Neuro-Psychopharmacology and Biological Psychiatry 64:250–58. doi:10.1016/j.pnpbp.2015.03.002.
  • Brown, T. K. 2013. Ibogaine in the treatment of substance dependence. Current Drug Abuse Reviews 6 (1):3–16. doi:10.2174/15672050113109990001.
  • Fischer, B., J. Rehm, S. Brissette, S. Brochu, J. Bruneau, N. El-Guebaly, L. Noel, M. Tyndall, C. Wild, P. Mun, and D. Baliunas. 2005. Illicit opioid use in Canada: Comparing social, health, and drug use characteristics of untreated users in five cities (OPICAN study). Journal of Urban Health: Bulletin of the New York Academy of Medicine 82 (2):250–66. doi:10.1093/jurban/jti049.
  • Glick, S. D., K. Rossman, S. Steindorf, I. M. Maisonneuve, and J. N. Carlson. 1991. Effects and aftereffects of ibogaine on morphine self-administration in rats. European Journal of Pharmacology 195 (3):341–45. doi:10.1016/0014-2999(91)90474-5.
  • Koenig, X., and K. Hilber. 2015. The anti-addiction drug ibogaine and the heart: A delicate relation. Molecules 20 (2):2208–28. doi:10.3390/molecules20022208.
  • Maisonneuve, I. M., R. W. Keller Jr., and S. D. Glick. 1991. Interactions between ibogaine, a potential anti-addictive agent, and morphine: An in vivo microdialysis study. European Journal of Pharmacology 199 (1):35–42. doi:10.1016/0014-2999(91)90634-3.
  • Mattick, R. P., C. Breen, J. Kimber, and M. Davoli. 2014. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database of Systematic Reviews 2:CD002207.
  • National Drug Intelligence Center. 2011. The economic impact of illicit drug use on American society. Washington, DC: United States Department of Justice.
  • Oviedo-Joekes, E., S. Brissette, D. C. Marsh, P. Lauzon, D. Guh, A. Anis, and M. T. Schechter. 2009. Diacetylmorphine versus methadone for the treatment of opioid addiction. The New England Journal of Medicine 361 (8):777–86. doi:10.1056/NEJMoa0810635.
  • Tupper, K. W., E. Wood, R. Yensen, and M. W. Johnson. 2015. Psychedelic medicine: A re-emerging therapeutic paradigm. Canadian Medical Association Journal 187 (14):1054–59. doi:10.1503/cmaj.141124.
  • Vashishtha, V. M. 2008. 2008 World Drug Report: A more pragmatic approach needed to combat illicit drug use. Indian Pediatrics 45 (9):767–68.
  • Ward, J., W. Hall, and R. P. Mattick. 1999. Role of maintenance treatment in opioid dependence. The Lancet 353 (9148):221–26. doi:10.1016/S0140-6736(98)05356-2.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.